JP2020532551A5 - - Google Patents

Download PDF

Info

Publication number
JP2020532551A5
JP2020532551A5 JP2020512687A JP2020512687A JP2020532551A5 JP 2020532551 A5 JP2020532551 A5 JP 2020532551A5 JP 2020512687 A JP2020512687 A JP 2020512687A JP 2020512687 A JP2020512687 A JP 2020512687A JP 2020532551 A5 JP2020532551 A5 JP 2020532551A5
Authority
JP
Japan
Prior art keywords
vinyl
isoindoline
bipyrimidine
pyridin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020512687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532551A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049225 external-priority patent/WO2019046795A1/en
Publication of JP2020532551A publication Critical patent/JP2020532551A/ja
Publication of JP2020532551A5 publication Critical patent/JP2020532551A5/ja
Pending legal-status Critical Current

Links

JP2020512687A 2017-09-03 2018-08-31 Rho関連コイルドコイルキナーゼ(ROCK)阻害剤としてのビニルヘテロ環 Pending JP2020532551A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762553885P 2017-09-03 2017-09-03
US62/553,885 2017-09-03
PCT/US2018/049225 WO2019046795A1 (en) 2017-09-03 2018-08-31 VINYL HETEROCYCLES AS INHIBITORS OF RHO (ROCK) ASSOCIATED BISPIRALIZED KINASE

Publications (2)

Publication Number Publication Date
JP2020532551A JP2020532551A (ja) 2020-11-12
JP2020532551A5 true JP2020532551A5 (cg-RX-API-DMAC7.html) 2021-10-14

Family

ID=65526110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020512687A Pending JP2020532551A (ja) 2017-09-03 2018-08-31 Rho関連コイルドコイルキナーゼ(ROCK)阻害剤としてのビニルヘテロ環

Country Status (8)

Country Link
US (1) US11542256B2 (cg-RX-API-DMAC7.html)
EP (1) EP3676262A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020532551A (cg-RX-API-DMAC7.html)
CN (1) CN111406051A (cg-RX-API-DMAC7.html)
AU (1) AU2018326785B2 (cg-RX-API-DMAC7.html)
CA (1) CA3073956A1 (cg-RX-API-DMAC7.html)
IL (1) IL272939A (cg-RX-API-DMAC7.html)
WO (1) WO2019046795A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11542256B2 (en) 2017-09-03 2023-01-03 Angion Biomedica Corp. Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
WO2021016256A2 (en) * 2019-07-22 2021-01-28 Angion Biomedica Corp. Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors
TW202132285A (zh) * 2019-11-13 2021-09-01 美商愛彼特生物製藥股份有限公司 經取代異吲哚啉基2,2’-聯嘧啶基化合物、其類似物及使用其之方法
CN116209658A (zh) * 2020-07-21 2023-06-02 安吉昂生物医药公司 Rho相关卷曲螺旋激酶的抑制剂
JP2025515296A (ja) * 2022-04-20 2025-05-14 シャンハイ ジムン バイオファーマ,インコーポレーテッド Rho関連プロテインキナーゼ阻害剤ならびにその調製および応用
CN119998295A (zh) 2022-06-08 2025-05-13 因赛特公司 作为dgk抑制剂的三环三唑并化合物
US12600723B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors
US12600722B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322756A (en) 1992-07-09 1994-06-21 Xerox Corporation Magnetic fluids and method of preparation
MY134008A (en) 1999-12-22 2007-11-30 Merck Frosst Canada Inc Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
WO2002072578A2 (en) 2001-03-08 2002-09-19 Millennium Pharmaceuticals (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases
DE102004039280A1 (de) * 2004-08-13 2006-02-23 Merck Patent Gmbh 1,5-Diphenyl-pyrazole
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
CA2660560A1 (en) * 2006-08-16 2008-02-21 Boehringer Ingelheim International Gmbh Pyrazine compounds, their use and methods of preparation
KR20090057032A (ko) 2006-09-21 2009-06-03 노파르티스 아게 사이토카인 매개 질환의 치료에 유용한 피롤 유도체
US7758972B2 (en) * 2006-09-26 2010-07-20 Semiconductor Energy Laboratory Co., Ltd. Stilbene derivative, light emitting element, light emitting device, and electronic appliance
CA2700988A1 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
KR101455428B1 (ko) 2007-02-28 2014-10-27 제이엔씨 석유 화학 주식회사 Cf2o 결합기를 갖는 5 고리 액정 화합물, 액정 조성물 및 액정 표시 소자
DE112008000841T5 (de) 2007-03-29 2010-02-11 Sumitomo Chemical Company, Limited Verbindung, photoelektrischer Wandler und photoelektrochemische Zelle
MX2011009568A (es) 2009-03-09 2011-12-06 Surface Logix Inc Inhibidores de la rho cinasa.
WO2011011312A1 (en) 2009-07-22 2011-01-27 Merck Sharp & Dohme Corp. Quinolinone pde2 inhibitors
NZ602191A (en) 2010-03-02 2014-07-25 Amakem Nv Heterocyclic amides as rock inhibitors
WO2012040499A2 (en) 2010-09-22 2012-03-29 Surface Logix, Inc. Metabolic inhibitors
JP5809954B2 (ja) 2011-12-15 2015-11-11 富士フイルム株式会社 光電変換素子及び色素増感太陽電池
RS63503B1 (sr) 2012-10-05 2022-09-30 Kadmon Corporation Llc Inhibitori rho kinaze
EP2961405A4 (en) 2012-12-14 2017-03-29 The Brigham and Women's Hospital, Inc. Methods and assays relating to macrophage differentiation
HUE033962T2 (en) 2013-01-29 2018-01-29 Redx Pharma Plc Pyridine derivatives as soft rock (RHO kinase) inhibitors
US11311541B2 (en) 2014-04-09 2022-04-26 Kadmon Corporation, Llc Treatment of GVHD
JP6310558B2 (ja) 2014-06-11 2018-05-16 富士フイルム株式会社 光電変換素子、色素増感太陽電池、金属錯体色素、色素溶液、およびターピリジン化合物またはそのエステル化物
US9902702B2 (en) * 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
US10011600B2 (en) 2014-09-25 2018-07-03 Araxes Pharma Llc Methods and compositions for inhibition of Ras
WO2016081554A1 (en) 2014-11-18 2016-05-26 Neostem Oncology, Llc Immunogenic compositions prepared from tumor cells derived from peripheral blood and originating from a solid tumor and their use
MX2017008844A (es) 2015-01-09 2018-03-14 Gilead Apollo Llc Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico.
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US9687483B2 (en) 2015-01-26 2017-06-27 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
ES2730112T3 (es) * 2015-03-09 2019-11-08 Bristol Myers Squibb Co Lactamas como inhibidores de ROCK
JP2018522942A (ja) 2015-05-29 2018-08-16 エッジ セラピューティクス インコーポレイテッド 視力障害を低減するための組成物及び方法
WO2016204256A1 (ja) 2015-06-16 2016-12-22 国立大学法人京都大学 高機能性血小板の製造方法
SG11201808625QA (en) 2016-04-04 2018-10-30 Chemocentryx Inc SOLUBLE C5aR ANTAGONISTS
JP2019112307A (ja) 2016-04-28 2019-07-11 宇部興産株式会社 置換ジヒドロピロロピラゾール化合物および他の乾癬治療薬が組み合わせて投与される医薬組成物
KR102444366B1 (ko) 2016-06-03 2022-09-19 케모센트릭스, 인크. 간 섬유화 치료 방법
CN107019698A (zh) 2016-08-04 2017-08-08 上海市第十人民医院 Rock2抑制剂在制备炎症性肠病药物中的应用
CA3036378A1 (en) 2016-09-13 2018-03-22 President And Fellows Of Harvard College Methods relating to intestinal organ-on-a-chip
KR101892154B1 (ko) 2017-02-22 2018-08-28 한국과학기술연구원 Rho-연관된 단백질 키나제 저해제를 포함하는 면역 반응 증강용 조성물 및 이를 이용한 방법
CN106916145B (zh) 2017-03-06 2019-06-04 上海应用技术大学 SLx-2119的合成方法
SG11201907673YA (en) 2017-03-13 2019-09-27 Genfit Pharmaceutical compositions for combination therapy
CN110573148A (zh) 2017-03-16 2019-12-13 武田有限公司 特发性肺纤维化的治疗
CA3058542A1 (en) 2017-04-18 2018-10-25 Genfit Combination comprising a ppar agonist such as elafibranor and an acetyl-coa carboxylase (acc) inhibitor
ES2982341T3 (es) 2017-06-30 2024-10-15 Quixgen Inc Nuevos compuestos de espirolactona
US11542256B2 (en) 2017-09-03 2023-01-03 Angion Biomedica Corp. Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
GB201715928D0 (en) 2017-09-30 2017-11-15 Auckland Uniservices Ltd Method
GB201715930D0 (en) 2017-09-30 2017-11-15 Upside Biotechnologies Ltd Cell Culture Medium
CN111741754A (zh) 2017-10-30 2020-10-02 凯莫森特里克斯股份有限公司 作为免疫调节剂的氘代化合物
WO2019099457A1 (en) 2017-11-14 2019-05-23 Quixgen, Inc. Benzodioxinone compounds
IL308604B2 (en) 2017-12-06 2025-08-01 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
MX2020006459A (es) 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillos fusionados 6,5 diaril sustituidos como inhibidores de c5ar.
MA51327A (fr) 2017-12-22 2021-05-26 Chemocentryx Inc Composés cycliques fusionnés en 5,5 à substitution diaryle, utilisés en tant qu'inhibiteurs du c5ar
ES2993034T3 (en) 2018-04-02 2024-12-20 Chemocentryx Inc Prodrugs of fused-bicyclic c5ar antagonists
US20190328721A1 (en) 2018-04-25 2019-10-31 Korea Institute Of Science And Technology Method of activating dendritic cells
CN110200972A (zh) 2019-05-10 2019-09-06 南京市儿童医院 Kd025在制备防治慢性肾纤维化的药物中的用途
WO2021016256A2 (en) 2019-07-22 2021-01-28 Angion Biomedica Corp. Ethynylheterocycles as rho-associated coiled-coil kinase (rock) inhibitors
CN116209658A (zh) 2020-07-21 2023-06-02 安吉昂生物医药公司 Rho相关卷曲螺旋激酶的抑制剂

Similar Documents

Publication Publication Date Title
AU2002363176B2 (en) Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)
EP3877376B1 (en) Pyridazinone compounds and uses thereof
ES2665036T3 (es) Bencilinazoles sustituidos para su uso como inhibidores de BUB1 cinasa en el tratamiento de enfermedades hiperproliferativas
RU2018138047A (ru) Гетероциклические вещества - агонисты gpr119
JP2004509113A5 (cg-RX-API-DMAC7.html)
JP2019510787A5 (cg-RX-API-DMAC7.html)
JP2014521653A5 (cg-RX-API-DMAC7.html)
JP2021502387A5 (cg-RX-API-DMAC7.html)
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2014532070A5 (cg-RX-API-DMAC7.html)
JP2010512338A5 (cg-RX-API-DMAC7.html)
JP2017510644A5 (cg-RX-API-DMAC7.html)
RU2018138050A (ru) Производные тиазолопиридина как агонисты gpr119
JP2009541311A5 (cg-RX-API-DMAC7.html)
RU2009125897A (ru) Ингибиторы фосфоинозитид-3-киназы и способы их применения
EA034872B1 (ru) Комбинация ингибитора mek кобиметиниба и ингибитора erk (s)-1-(1-(4-хлор-3-фторфенил)-2-гидроксиэтил)-4-(2-((1-метил-1h-пиразол-5-ил)амино)пиримидин-4-ил)пиридин-2(1h)-она для применения в лечении раковых заболеваний
RU2011137399A (ru) Гетероциклическое производное
JP2016519096A5 (cg-RX-API-DMAC7.html)
JP2008526692A5 (cg-RX-API-DMAC7.html)
JP2015164972A5 (cg-RX-API-DMAC7.html)
EP2785714A1 (en) Improved modulators of hec1 activity and methods therefor
KR20170007868A (ko) Bcr-abl, c-kit, ddr1, ddr2 또는 pdgf-r 키나제 활성에 의해 매개된 증식성 장애 및 다른 병적 상태의 치료 방법
JP2011530607A5 (cg-RX-API-DMAC7.html)
JP2019501937A5 (cg-RX-API-DMAC7.html)
JP2020503293A5 (cg-RX-API-DMAC7.html)